Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

February 8, 2017 by Alan Khadavi

ZPL389, New Oral Eczema Drug in the Pipeline

opzelura vs zoryve

ZPL389 is a new once-daily oral H4 receptor antagonist that is currently being studied for the treatment of atopic dermatitis, commonly referred as eczema. Novartis recently purchased the rights to this medication from Ziarco, a private company focused on the development of treatments in dermatology.  There currently is no specific oral medication used for the […]

Filed Under: atopic dermatitis, Blog

February 7, 2017 by Alan Khadavi

AllergyLosAngeles.com named Top Allergy Blog

top allergy blog

We are proud to announce that our blog, was named one of the top 10 allergy blogs in the world by feedspot.com Top Allergy Blogs The list was based on quality of articles, quality and consistency of posts, social media influence and Feedspot’s editorial team and expert review. Being picked as a top allergy blog […]

Filed Under: Blog, Headlines

January 30, 2017 by Alan Khadavi

New Peanut Guidelines

peanut guidelines

New peanut guidelines have been officially introduced by the National Institute of Allergy and Infectious Diseases in response to the earlier studies we have discussed from the LEAP trials. Peanut Allergy Prevention Peanut allergy is a growing public health problem.  In the United States, peanut allergy prevalence is approximately 2% among children.  Peanut allergy is […]

Filed Under: Blog, Food allergy, Headlines, Uncategorized

January 25, 2017 by Alan Khadavi

Alternative Agents for Refractory Chronic Urticaria Patients

ruxolitinib

Chronic urticaria is defined for a period of at least 6 weeks with hives.  Patients with chronic urticaria who fail high-dose antihistamines should be referred to an allergy specialist to help manage their condition.  We have previously spoke about the stepwise approach to chronic idiopathic/spontaneous urticaria. Stepwise approach to Chronic Urticaria (Chronic Hives) Patients with […]

Filed Under: Blog, hives, Urticaria

January 19, 2017 by Alan Khadavi

Auvi-Q to return to market

Auvi-Q to return

Auvi-Q is set to return to the market February 14, 2017.  Auvi-Q was withdrawn off the market in the past because improper dosing and later it was sold to Kaleo. Auvi-Q Recall Many were wondering if Auvi-Q would ever return to the market again.  Many patients liked the small packaging and the fact that it […]

Filed Under: Anaphylaxis, Blog, Headlines

January 11, 2017 by Alan Khadavi

Eucrisa (crisaborole) New Eczema Medication gets FDA Approval

Eucrisa (crisabole)

Eucrisa (crisaborole) recently won FDA approval for eczema (atopic dermatitis).  This would be the first non-steroidal skin therapy for eczema in 15 years, since Elidel and Protopic were approved.  Pfizer recently bought the rights to Eucrisa (crisaborole) back in May when it acquired its developer, Anacor, for 5.2 billion dollars. There were 2 trials, consisting […]

Filed Under: atopic dermatitis, Blog

January 3, 2017 by Alan Khadavi

Does Xolair Work for Eczema?

opzelura vs zoryve

Does Xolair work for eczema?  Is a question that has been asked by many atopic dermatitis sufferers since the drug came out.  Omalizumab targets IgE and many patients with eczema have extremely high levels of IgE.  The only problem is that it approved for patients who have asthma whose IgE go up to 700 IU/ml, […]

Filed Under: Allergy Medicine, atopic dermatitis, Blog

December 29, 2016 by Alan Khadavi

Sublingual Dust Mite Immunotherapy

odactra

Sublingual dust mite immunotherapy tablets are currently being developed by Merck.  House dust mite is the most common cause of perennial allergic rhinitis worldwide.  Symptoms of house dust mite allergies can be treated with medications or allergy immunotherapy, currently available in the shot form or sublingual drops.  The sublingual drops have shown good efficacy is […]

Filed Under: Blog, Immunotherapy

December 23, 2016 by Alan Khadavi

HBO’s ‘The Night Of’ and Eczema

opzelura vs zoryve

For those of you who watched HBO’s drama ‘The Night Of’, you would have seen one of the many characters, John Stone played by John Turturro suffer from eczema (atopic dermatitis).  If you have not seen this mini-series yet, do not worry this blog post contains no spoilers central to the main plot line. As […]

Filed Under: atopic dermatitis, Blog, Headlines

December 22, 2016 by Alan Khadavi

Does High Alcohol Consumption Cause Allergies?

does alcohol cause allergies

Does high alcohol consumption cause allergies?  That is question many have wondered as patients with alcohol intake have complained about allergy symptoms.  To measure this, scientists measured the IgE levels in patients.  IgE is thought to play an important role in allergic diseases, such as asthma, allergic rhinitis and allergic eczema.  Thus high total IgE […]

Filed Under: Blog, Headlines

  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 57
  • Next Page »

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page